Real-world data-based assessment of therapy-related myeloid neoplasms after poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer

BackgroundPoly(ADP-ribose) polymerase inhibitors (PARPi) have significantly improved outcomes in ovarian cancer. However, therapy-related myeloid neoplasms (t-MNs) have emerged as rare but serious late complications. Although an increased incidence of t-MNs has been reported following PARPi exposure...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, Mikako Inoue, Katsuhiko Mizuno, Kosuke Yoshida, Nobuhisa Yoshikawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-01-01
Col·lecció:	Frontiers in Oncology
Matèries:	myelodysplastic syndrome ovarian cancer PARP inhibitors real-world data therapy-related myeloid neoplasms
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1728766/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!